I-GLP-1 i-Amino ekhuselweyo ye-GLP-1 ye-Amino Acid yoLungiso lwe-Hiin
Iinkcukacha zemveliso
| HAYI. | Iimveliso | I-CASS No. | Isicelo | Isalathiso seXabiso eliPhambili | ||||
| Ubunyulu | Isomer | Yi * | Max * | Ukufuma | ||||
| 1 | I-Fmoc-lys (MTT) -oh | 167393-62-6 | I-Lysine icala le-Lysine | ≥99.0% | ≤0.1% | ≤0.2% | ≤0.3% | ≤1.0% |
| 2 | I-FMOC-lys (Alloc) -oh | 146982-27-6-6 | I-Lysine icala le-Lysine | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 3 | I-FMOC-lys (ivdde) -oh | I-150629-67-7 | I-Lysine icala le-Lysine | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 4 | I-FMOC-lys (MMT) -oh | I-159857-60-60-0 | I-Lysine icala le-Lysine | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
| 5 | I-FMOC-glu-otbu | I-84793-07-7 | LiraglutideSemaglutide | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 6 | Glu-otbu | I-45120-30-7 | LiraglutideSemaglutide | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
| 7 | I-octadecanediociocioc acid | I-871-70-5 | Semaglutide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 8 | I-octadecanediocaneciocioc acid mono-terter-terter | I-843666-40-0-0 | Semaglutide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 9 | I-TBBU-OOC-C16-CO-GLU-OTBU | 1188328-39-39-3 | SemaglutideIsiqwenga a | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 10 | Aeea | 134978-97-5 | SemaglutideAlbvite | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 11 | Aeea-oh.hcl | 134979-01-4 | SemaglutideAlbvite | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 12 | I-FMOC-AEEA-OH | 166108-71-0-0 | SemaglutideAlbvite | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 13 | Boc-aeea-oh | I-108466-89-3 | Semaglutide | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 14 | Aeea-Aeea | I-1143516-05-5 | Semaglutide | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 15 | I-Fmoc-Aeea-Aeea-oh | I-560088-89-3 | SemaglutideIsiqwenga b | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 16 | I-OCTA (OTBU) -Glu (ɑ-oTBU) -aea-Aeea-oh | I-1118767-0-0 | SemaglutideUkuqhekeka c | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 17 | I-TBBU-OOC-C16-CO-GLU (AEEA-AEEA-NHS) -OTO | I-1118767-15-9 | SemaglutideIsiqwenga d | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 18 | I-Fmoc-lys (Tbu-Ooc-C16-CO-GLU (AEEA-AEEA) -OOOH | 1662688-20-1 | Isiqwenga se-semaglutide e | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 19 | I-Boc-yakhe (i-TRT) -oh | 32926-43-5 | Isiphelo si-histidine | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤4.0% |
| 20 | I-FMOC-AIB | I-94744-50-50-0 | Semaglutide | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
| 21 | I-Boc-yakhe (i-TRT) -aib-oh | 2061897-68-3 | Semaglutide | ≥99.0% | ≤0.1% | ≤0.2% | ≤0.3% | ≤2.0% |
| 22 | I-FMOC-glu (otbu) -Gly-oh | I-866044-63-5 | I-GLP-1 i-analogue | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 23 | I-Boc-yakhe (i-TRT) -aiib-glu (otbu) -U-oh | 1169630-31-21-2? | Isiqwenga se-semaglutide f | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 24 | I-BOC-yakhe (i-TRT) -aib-glu (otbu) -Gly-NHS | I-1169630-40-30-3 | Isiqwenga se-semaglutide g | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 25 | I-FMOC-ARG (PBF) -Gly-oh | I-660846-80-0-0 | I-GLP-1 i-analogue | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 26 | I-FMOC-ALA-OH | I-87512-31-0-0 | I-GLP-1 i-analogue | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 27 | I-FMOC-TARE (TBU) -Oh-oh | 12609-75-13? | I-GLP-1 i-analogue | ≥99.5% | ≤0.1% | ≤0.2% | ≤0.2% | ≤1.0% |
| 28 | I-Palmic Acid | Ngo-1957 / 10/3 | I-LiraGlutide ibe qhayiso 1 | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 29 | I-Palm-Glu-otbu | NA | I-Liraglutide ibe qhayiso 2 | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 30 | I-Palm-Glu (Nes) -otbu | NA | I-Liraglutide ibekihlisi 3 | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
| 31 | I-FMOC-lys (i-Palm-Glu-oTbu) -oh | 1491158-62-3 | Liraglutide | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 32 | I-hexadecadioneciocioc acid | I-505-54-4 | I-insulin phantsi | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 33 | Hexadecadionediocioc acid mono-terter-terter-tert-bterster | I-84366-27-73 | I-insulin phantsi | ≥99.0% | / | ≤0.2% | ≤0.3% | ≤1.0% |
| 34 | I-TBBU-OOC-C14-CO-GLU-OTBHU | NA | I-Insulin Dardackec | ≥98.0% | ≤0.2% | ≤0.5% | ≤0.5% | ≤1.0% |
| 35 | I-TBBU-OOC-C14-CO-GLU (Nes) -otbu | NA | I-insulin hladaki i-II | ≥96.0% | ≤0.5% | ≤1.0% | ≤1.0% | ≤1.0% |
SI * = Ukungcola okuthile
UMax * = i-max engaziwayo
Olunye uphawu:
-I-acetic acid: ≤0.02% (zonke iimveliso)
- I-Ethyl Acetate: ≤0.5% (Zonke iimveliso)
-Utywala: ≤0.5% (zonke iimveliso)
Isiphene
Ukugwetywa kwenkqubo yokuhambisa, kubandakanya i-loop kunye netanki yokugcina yenziwa yi-pasterization. Xa kusenziwa isijwili se-pasteriting, amanzi acocekileyo etanki ifudusele kwi-80 ° C kwaye aqalise ukujikeleza inkqubo yokuhambisa. I-sondling ihlala i-1 iyure emva kokufikelela kwi-80 ° C. Ucoceko lwenziwa kwikota nganye. Inkqubo yenkqubo ye-System ecocekileyo ye-Sungercial itshekishwe ngaphandle kohambo eboniswe.
